Počet záznamov: 1  

Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions

  1. SYSr027723
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617160534.9
    100
      
    $a 20040706a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions $f U. Coskun ... [et al.]
    215
      
    $c Graf, tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_003 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 3 (2004), p. 209-213 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Hepatocytárny rastový faktor v sére a hladina interleukínu-6 môže rozlíšiť pacientov s primárnymi alebo metastatickými tumormi od benigných lézii pečene
    606
    1-
    $3 sllk_un_auth*d017228 $a faktor rastový hepatocytový $x analýza $x použitie diagnostické $9 . $2 mesh
    606
    1-
    $a interleukín-6 $x analýza $x použitie diagnostické $2 mesh $3 sllk_un_auth*d015850 $9 .
    606
    1-
    $a nádory pečene $x klasifikácia $x diagnostika $x farmakoterapia $2 mesh $3 sllk_un_auth*d008113 $9 .
    606
    2-
    $a metastázy nádorové $x patológia $2 mesh $3 sllk_un_auth*d009362 $9 .
    606
    2-
    $a karcinóm hepatocelulárny $x diagnostika $x farmakoterapia $2 mesh $3 sllk_un_auth*d006528 $9 .
    606
    2-
    $a nádory prsníka $x diagnostika $x farmakoterapia $2 mesh $3 sllk_un_auth*d001943 $9 .
    606
    2-
    $a progresia choroby $2 mesh $3 sllk_un_auth*d018450 $9 .
    675
      
    $a 616.36-006-07-08 $v 2. $z slo
    701
    -1
    $a Coskun $b U. $3 sllk_un_auth*p0066022 $4 070 $p Department of medical oncology, Gazi university, Medical school, Ankara, Turkey
    701
    -1
    $a Bukan $b N. $3 sllk_un_auth*p0034165 $4 070 $p Department of medical biochemistry, Gazi university, Medical school, Ankara, Turkey
    701
    -1
    $a Sancak $b B. $3 sllk_un_auth*p0030316 $4 070 $p Department of medical biochemistry, Gazi university, Medical school, Ankara, Turkey
    701
    -1
    $a Günel $b N. $3 sllk_un_auth*p0066024 $4 070 $p Department of medical oncology, Gazi university, Medical school, Ankara, Turkey
    701
    -1
    $a Ozenirler $b S. $3 sllk_un_auth*p0036699 $4 070 $p Department of medical gastroenterology, Gazi university, Medical school, Ankara, Turkey
    701
    -1
    $a Unal $b A. $3 sllk_un_auth*p0036700 $4 070 $p Department of medical biochemistry, Gazi university, Medical school, Ankara, Turkey
    701
    -1
    $a Yucel $b A. $3 sllk_un_auth*p0036701 $4 070 $p Department of medical immunology, Gazi university, Medical school, Ankara, Turkey
    801
    -0
    $a SK $b BA006 $c 20040706 $g AACR2
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.